Skip to main content
Công ty Cổ phần Dược phẩm Cửu Long logo

Công ty Cổ phần Dược phẩm Cửu Long — Investor Relations & Filings

Ticker · DCL ISIN · VN000000DCL1 HSX Manufacturing
Open in API
Filings indexed 224 across all filing types
Latest filing 2021-04-20 Annual Report
Country VN Viet Nam
Listing HSX DCL

About Công ty Cổ phần Dược phẩm Cửu Long

http://dcl.com.vn

Cuu Long Pharmaceutical Joint Stock Company (DCL) is a diversified healthcare provider with nearly 50 years of operational history. The company's core activities include the production of pharmaceuticals, medical equipment, and empty hard capsules. DCL is a market leader in empty hard capsules, holding approximately 80% market share. Its pharmaceutical portfolio comprises a range of drugs, chemicals, and medicines. The company serves a broad network of hospitals and medical facilities through an extensive distribution system. DCL is recognized for its commitment to delivering innovative and accessible healthcare products.

Recent filings

Filing Released Lang Actions
DCL: Báo cáo thường niên năm 2020
Annual Report Classification · 93% confidence The document is a comprehensive “Báo cáo thường niên năm 2020” (Annual Report 2020) from a listed Vietnamese pharmaceutical company, complete with detailed sections on corporate information, history, governance, segment results, financial performance, risks, and references to audited consolidated financial statements. It is clearly the primary yearly report covering company activities and full financial performance, not merely an announcement or supplement. Therefore, it is classified as an Annual Report (10-K). FY 2020
2021-04-20 Vietnamese
DCL: Quyết định của HĐQT về việc bổ nhiệm lại Kế toán trưởng Công ty
Board/Management Information Classification · 98% confidence The document is a company Board Resolution (‘Quyết định’) appointing/re-appointing the Chief Accountant, which is a senior management change. It is not a financial report, but an announcement of a management appointment by the board of directors.
2021-04-16 Vietnamese
DCL: Thông báo đơn từ nhiệm Thành viên BKS
Board/Management Information Classification · 90% confidence The document is a public disclosure filed to the State Securities Commission and HOSE announcing the resignation of a member of the company’s Supervisory Board (a governance/board body). This constitutes a management/board personnel change, matching the definition of Board/Management Information.
2021-03-31 Vietnamese
DCL: Link công bố tài liệu họp ĐHĐCĐ thường niên năm 2021
AGM Information Classification · 88% confidence The document is a formal disclosure to the State Securities Commission and Ho Chi Minh Stock Exchange publishing the company’s Annual General Meeting 2021 materials (“Tài liệu họp Đại hội đồng cổ đông thường niên 2021”) and attaches those materials. This fits the definition of AGM Information (presentations/materials for the AGM). It is not merely announcing a report but providing meeting documents for the AGM.
2021-03-31 Vietnamese
DCL: Thông báo thời gian, địa điểm chính thức họp ĐHĐCĐ thường niên 2021
Regulatory Filings Classification · 75% confidence The document is a formal announcement to regulatory authorities (SSC and HCMC Stock Exchange) regarding the official date, time, and venue for the company’s 2021 Annual General Meeting of Shareholders. It does not include AGM materials or minutes, proxy statements, voting results, financial data, or any substantive report; it is simply a notice of meeting logistics. This falls under general regulatory announcements that do not fit a more specific category.
2021-03-31 Vietnamese
DCL: Giải trình biến động LNST năm 2020 so với cùng kỳ năm trước
Regulatory Filings Classification · 70% confidence The document is a standalone explanatory letter sent to the State Securities Commission and the Ho Chi Minh Stock Exchange under Circular 155/2015/TT-BTC, detailing the year-over-year change in profit after tax. It is not a full annual report (10-K), not an earnings release (ER) (since it’s a post-result explanation rather than an initial results announcement), and not a financial supplement spreadsheet. It is a mandatory regulatory disclosure explaining financial variances. Thus it fits the “Regulatory Filings” (RNS) fallback for compliance disclosures.
2021-03-31 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.